AVANT BIO

We’re thrilled to announce that Jessica Davis, Principal at AVANT BIO, will participate in the upcoming Virtual Salon: Trendwatching for Early Stage TechBio Companies, co-organized by Demy-Colton and EBD Group! This insightful event is part of the 2024 TechBio series, bringing together key voices to discuss emerging trends shaping the future of early-stage TechBio companies. Jessica will be sharing her perspective on navigating opportunities in this exciting space. Wednesday, December 4th 11:00-12:15pm ET  https://lnkd.in/gn-A6KqK A huge thank you to Demy-Colton and EBD Group for creating this incredible platform to foster collaboration and innovation in the TechBio ecosystem. #TechBio #Innovation #LifeSciences #AVANTBIO

Exciting news from the AVANT BIO team! Jessica Davis will be participating in the 2024 TechBio Virtual Salon panel, exploring cutting-edge trends and innovations shaping the future of life sciences and biotech. We’re thrilled to have Jessica represent our vision and share insights on the transformative impact of technology in advancing healthcare. Don’t miss this opportunity to hear from industry thought leaders! Register now and join the conversation: https://lnkd.in/ew5Sq_gP #TechBio #LifeSciences #Innovation #Biotech

We were thrilled to participate in BioFuture™ 2024 hosted by Demy-Colton, where innovation and investment in the life sciences take center stage. A big thank you to the organizers for including our Founding GP, Daniella Kranjac, in the panel discussions alongside industry leaders shaping the future of biotech and healthcare. Exciting conversations and invaluable connections. Read the full event wrapup here: https://lnkd.in/geTJMDaj #LifeSciences #Innovation #BioFuture2024 #AVANTBIO #TechBio

We applaud the incredible women recognized as Fierce Pharma's Fiercest Women in Life Sciences 2024 and their groundbreaking contributions! 🎉   While we celebrate their accomplishments, it’s important to reflect on the broader picture. Despite women comprising nearly 50% of the life sciences workforce, fewer than 28% reach C-suite roles—a stark reminder of the barriers still faced by women striving for leadership positions.    At AVANT BIO, we’re proud to champion women breaking barriers in this space. We’re especially honored that our Founding GP, Daniella Kranjac, was recognized as one of the Fiercest Women in Life Sciences in 2022.   To all the remarkable women making an impact—you inspire us to push boundaries, challenge norms, and continue building a future where leadership knows no gender. 👏   #FierceWomen #Leadership #LifeSciences #WomenInSTEM #AvantBio

In today's challenging funding landscape, AVANT BIO recognizes a critical gap in financing for early-growth stage life science companies. These companies have achieved early commercial traction but struggle to secure the capital necessary to scale and drive meaningful impact. At AVANT BIO, we view this stage as a unique opportunity. Our deep expertise and strategic network empower us to support these companies through critical growth milestones, helping them bridge the gap from promising innovations to impactful market players. Read the full article to learn more about how AVANT BIO is tackling the funding gap for early-growth life science companies. #AVANTBIO #LifeSciences #FundingGap #EarlyGrowth #BiotechInvestment #HealthcareInnovation #GrowthEquity

AVANT BIO is excited to partner with PL BioScience GmbH in advancing its comprehensive portfolio of HPL products. This advanced portfolio serves as an alternative to traditional cell culture supplements, offering a consistent, animal-free, and ethically sourced option. Their HPL technology enables more reliable and standardized cell culture, which is critical for research and therapeutic applications, especially within the cell and gene therapy markets. These are a few reasons why we are excited to have invested in PL BioScience, read the full article to learn more about what attracted us to this opportunity. #AVANTBIO #LifeSciences #BiotechInvestment #GlobalPartnerships #HealthcareInnovation #growthequity #cellandgenetherapies

🚀 Proud to support PathPresenter in their journey toward revolutionizing digital pathology! PathPresenter, a valued AVANT BIO portfolio company, is building a comprehensive ecosystem to democratize access to the world’s pathology knowledge. With their recent partnership with Paige, PathPresenter is poised to accelerate the adoption of image management and AI-enhanced workflows, empowering pathologists worldwide. This collaboration will revolutionize digital pathology workflows in hospitals and laboratories worldwide by integrating Paige's advanced Diagnostic AI applications directly into PathPresenter's platform. Congratulations to the teams at PathPresenter and Paige on this impactful step forward! 👏 Press Release: https://lnkd.in/g-HgSZ_W #DigitalPathology #HealthcareInnovation #Pathology #AI #Healthtech https://lnkd.in/gGQ_qnwP

📢 Just released - Our Q3 LS Industrials, Healthtech & Techbio News and Analysis. The life sciences sector has shown steady resilience and selective growth, with M&A activity returning to a stable baseline and key acquisitions redefining industry dynamics. September sparked renewed energy in the market, hinting at cautious optimism ahead. Demand is rising, and strategic players are seeing improvement, suggesting a promising path for continued growth. Dive into the full report to explore the latest trends and insights shaping the future of life sciences! #healthtech #techbio #enablingtherapeutictechnologies #marketanalysis

Daniella Kranjac will be a guest panelist at Demy-Colton's #BioFuture2024! The panel. Navigating New Horizons: Unlocking Opportunities in TechBio will delve into the emerging opportunities in the TechBio sector, examining how technological advancements are revolutionizing biological research and applications including drug discovery tools, advances in personalized medicine, streamlining clinical trials and enhancing disease diagnosis and management. Daniella will be joined by panelists: Konstantina Katcheves: Senior Vice President, Innovation Medicines Business Development and Acquisitions, Teva Pharmaceuticals  Viq Pervaaz: Senior Vice President, New York City Economic Development Corporation  Ajit Singh: Partner, Artiman Ventures Registration details below: #growthequity #techbio #biotech https://lnkd.in/eG7hUXXp

Don't miss these insights from Sebastien Latapie's latest discussion on UseofFunds hosted by Weave & Pitch. Sebastien spoke on the topic "Traction And Sales Pipeline in Early Stage Biotech", a must hear for any founder. https://lnkd.in/eMTn5FGt #growthequity #innovation #startup